Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHEAL COLEMAN SCRUGGS

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1871573394
CMS profile
445355
Location
RUTHERFORDTON, NC

General Payments · PY2018–2022

$37,365.51

  • Reported across 64 records
  • CMS publication 2026-01-23

Latest program year · PY2022

$15,140.93

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $15,140.93 30

By paying entity

PY2022 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $15,140.93 30

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,599.58 15
PY2020 $5,760.00 6
PY2021 $11,865.00 13
PY2022 $15,140.93 30

Payment records · PY2022 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2022 201820202021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Novartis Pharmaceuticals Corporation $750.00 01/09/2022 Consulting Fee Undisputed 01/23/2026 894342997 CMS
Novartis Pharmaceuticals Corporation $142.80 01/09/2022 Consulting Fee Undisputed 01/23/2026 894343057 CMS
Novartis Pharmaceuticals Corporation $750.00 01/10/2022 Consulting Fee Undisputed 01/23/2026 894343001 CMS
Novartis Pharmaceuticals Corporation $142.80 01/10/2022 Consulting Fee Undisputed 01/23/2026 894343061 CMS
Novartis Pharmaceuticals Corporation $750.00 02/26/2022 Consulting Fee Undisputed 01/23/2026 894343005 CMS
Novartis Pharmaceuticals Corporation $187.20 02/26/2022 Consulting Fee Undisputed 01/23/2026 894343065 CMS
Novartis Pharmaceuticals Corporation $750.00 02/28/2022 Consulting Fee Undisputed 01/23/2026 894343009 CMS
Novartis Pharmaceuticals Corporation $46.80 02/28/2022 Consulting Fee Undisputed 01/23/2026 894343069 CMS
Novartis Pharmaceuticals Corporation $750.00 03/01/2022 Consulting Fee Undisputed 01/23/2026 894343013 CMS
Novartis Pharmaceuticals Corporation $221.37 03/01/2022 Consulting Fee Undisputed 01/23/2026 894343073 CMS
Novartis Pharmaceuticals Corporation $750.00 03/08/2022 Consulting Fee Undisputed 01/23/2026 894343017 CMS
Novartis Pharmaceuticals Corporation $90.68 03/08/2022 Consulting Fee Undisputed 01/23/2026 894343077 CMS
Novartis Pharmaceuticals Corporation $750.00 03/13/2022 Consulting Fee Undisputed 01/23/2026 894343021 CMS
Novartis Pharmaceuticals Corporation $18.14 03/13/2022 Consulting Fee Undisputed 01/23/2026 894343081 CMS
Novartis Pharmaceuticals Corporation $850.00 04/26/2022 Consulting Fee Undisputed 01/23/2026 894343025 CMS
Novartis Pharmaceuticals Corporation $600.36 04/26/2022 Consulting Fee Undisputed 01/23/2026 894343085 CMS
Novartis Pharmaceuticals Corporation $750.00 07/26/2022 Consulting Fee Undisputed 01/23/2026 894343029 CMS
Novartis Pharmaceuticals Corporation $455.50 07/26/2022 Consulting Fee Undisputed 01/23/2026 894343089 CMS
Novartis Pharmaceuticals Corporation $750.00 08/06/2022 Consulting Fee Undisputed 01/23/2026 894343033 CMS
Novartis Pharmaceuticals Corporation $301.25 08/06/2022 Consulting Fee Undisputed 01/23/2026 894343093 CMS
Novartis Pharmaceuticals Corporation $750.00 09/28/2022 Consulting Fee Undisputed 01/23/2026 894343037 CMS
Novartis Pharmaceuticals Corporation $568.50 09/28/2022 Consulting Fee Undisputed 01/23/2026 894343097 CMS
Novartis Pharmaceuticals Corporation $750.00 10/05/2022 Consulting Fee Undisputed 01/23/2026 894343041 CMS
Novartis Pharmaceuticals Corporation $84.38 10/05/2022 Consulting Fee Undisputed 01/23/2026 894343101 CMS
Novartis Pharmaceuticals Corporation $850.00 10/21/2022 Consulting Fee Undisputed 01/23/2026 894343045 CMS
Novartis Pharmaceuticals Corporation $498.65 10/21/2022 Consulting Fee Undisputed 01/23/2026 894343105 CMS
Novartis Pharmaceuticals Corporation $850.00 11/30/2022 Consulting Fee Undisputed 01/23/2026 894343049 CMS
Novartis Pharmaceuticals Corporation $142.50 11/30/2022 Consulting Fee Undisputed 01/23/2026 894343107 CMS
Novartis Pharmaceuticals Corporation $750.00 12/06/2022 Consulting Fee Undisputed 01/23/2026 894343053 CMS
Novartis Pharmaceuticals Corporation $90.00 12/06/2022 Consulting Fee Undisputed 01/23/2026 894343111 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2020, 2021, 2022
Source files
Dataset page · Bulk file · PY2018 , PY2020 , PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.